Mode
Text Size
Log in / Sign up

New analysis shows intravenous efgartigimod helps many myasthenia gravis patients feel better and reduces symptoms quickly

Share
New analysis shows intravenous efgartigimod helps many myasthenia gravis patients feel better and re…
Photo by Navy Medicine / Unsplash

This study looked at how well a specific medicine works for people with myasthenia gravis. The medicine is given through a vein and helps the body clear out antibodies that cause muscle weakness. Researchers combined information from many different groups to get a clear picture of the results.

Most patients saw a big drop in their muscle weakness scores. About eighty-three percent of people had a meaningful improvement in how they felt. Another thirty-six percent reached a state where they had almost no symptoms at all. The medicine also helped lower the levels of the proteins that cause the disease.

People who took the medicine used fewer steroid pills and felt better overall. However, the study did not find enough information about patients who did not have a specific type of antibody. The medicine was generally safe, with only a small number of patients stopping treatment due to side effects.

What this means for you:
This medicine helps most patients with myasthenia gravis feel better and reduces symptoms, but results were not seen in all patient groups.
Share
More on Myasthenia Gravis